Bringing Cure... Building Hope...
For Urgent Support

urgent@indianpharmanetwork.co.in

24/7 Free Support

info@indianpharmanetwork.co.in

Call US

+91 9891296838 / 9811747774

JAKAFI (ruxolitinib) tablets, for oral use Initial U.S. Approval: 2011. Available in India.

Ruxolitinib is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea. Brand JAKAFI (ruxolitinib) tablets Can be imported and made available on "Patient Name basis" treatment in India. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.



  1. Home
  2. Melanoma Treatment
  3. Trade Name

JAKAFI (ruxolitinib) tablets is used for the treatment of patients with myelofibrosis or polycythemia vera, which are bone marrow disorders.

Jakafi is a kinase inhibitor indicated for treatment of: • intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelof • polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea. • steroid-refrac.

JAKAFI (ruxolitinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of JAKAFI (ruxolitinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the JAKAFI (ruxolitinib) tablets medicine cost price in India.

The order for JAKAFI (ruxolitinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Ruxolitinib is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body's ability to produce blood cells.

JAKAFI® (ruxolitinib) tablets, for oral use Initial U.S. Approval: 2011

Generic Name: ruxolitinib

Tablets: 5 mg, 10 mg, 15 mg, 20 mg and 25 mg

Ruxolitinib

JAKAFI (ruxolitinib) tablets injection is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | MUMBAI | BENGALURU | KOLKATA | LUCKNOW | JAIPUR | JODHPUR | PUNJAB | CHANDIGARH
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

JAKAFI (ruxolitinib) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand JAKAFI (ruxolitinib) tablets on prescription and Import License in Patient's Name only.

For overseas patients, JAKAFI (ruxolitinib) tablets can be made available in Send your enquiry to find JAKAFI (ruxolitinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for JAKAFI (ruxolitinib) tablets.

For JAKAFI (ruxolitinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Ruxolitinib Shows Noteworthy Responses in Patients With Rare Leukemias

Ongoing Research Poised to Add Options for Myelofibrosis Treatment For More Details

Get Access To FDA Approved Drug JAKAFI (ruxolitinib) tablets In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in myelofibrosis (a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production) treatment. Brand Name "JAKAFI (ruxolitinib) tablets" or Generic Name "ruxolitinib tablets" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.